Associated reactions after stroke: A randomized controlled trial of the effect of botulinum toxin type A

Journal of Rehabilitation Medicine

Volumn 40, Issue 1, 2008, Pages 36-41

  Bhakta, Bipin B ^a   O'Connor, Rory J ^a   Cozens, J Alastair ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b WOODEND HOSPITAL   (United Kingdom)

Author keywords

Associated reaction; Botulinum toxin; Stroke

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DYNAMOMETRY; ELBOW; FEMALE; FINGER; FLEXOR MUSCLE; HAND GRIP; HUMAN; MALE; PARALLEL DESIGN; PARESIS; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SPASTICITY; STROKE; WRIST;

AGED; BOTULINUM TOXIN TYPE A; FEMALE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PARESIS; STROKE;

EID: 38849092630     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0120     Document Type: Article

References (20)

1. Brunnstrom S. Associated reactions of the upper extremity in adult patients with hemiplegia; an approach to training. Phys Ther Rev 1956; 36: 225.
2. Blin O, Rascol O, Azulay JP, Serratrice G, Nieoullon A. A single report of hemiplegic arm stretching related to yawning: further investigation using apomorphine administration. J Neurol Sci 1994; 126: 225.
3. Twitchell TE. The restoration of motor function following hemiplegia in man. Brain 1951; 74: 443-480.
4. Mulley G. Associated reactions in the hemiplegic arm. Scand J Rehabil Med 1982; 14: 117-120.
5. Blower P. The advantages of the early use of wheelchairs in the treatment of hemiplegia. Clin Rehabil 1988; 2: 323-325.
6. Ashburn A, Lynch M. Disadvantages of the early use of wheelchairs in the treatment of hemiplegia. Clin Rehabil 1988; 2: 327-331.
7. Cornall C. Self-propelling wheelchairs: the effects on spasticity in hemiplegic patients. Physiother Theory Pract 1991; 7:13.
8. Bobath B, editor. Adult hemiplegia: evaluation and treatment. London: William Heinemann Medical Books; 1970.
9. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000; 14: 5-13.
10. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002; 347: 395-400.
11. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosur Psychiatry 2000; 69: 217-221.
12. Rossetto O, Montecucco C. How botulinum toxins work. In: Moore AP, Naumann M, editors. Handbook of botulinum toxin treatment. 2nd ed. Oxford: Blackwell Science; 2003. p. 9-27.
13. Macfarlane A, Turner-Stokes L, De Souza L. The associated reaction rating scale: a clinical tool to measure associated reactions in the hemiplegic upper limb. Clin Rehabil 2002; 16: 726-735.
14. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Intl Disabil Stud 1988; 10: 61-63.
15. Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996; 61: 30-35.
16. Geiringer SR. editor. Anatomic localization for needle electromyography. 2nd edn. Philadelphia: Hanley & Belfus; 1999.
17. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Quantifying associated reactions in the paretic arm in stroke and their relationship to spasticity. Clin Rehabil 2001; 15: 195-206.
18. Wade DT. Goal planning in stroke rehabilitation: what? Topics Stroke Rehabil 1999; 6: 8-15.
19. Esquenazi A, Mayer N, Wang J, Talaty M, Garreta R. Effect of decreased elbow spasticity on hemiparetic gait. Acta Fisiatrica 2005; 12 Suppl 1: S86-S87.
20. Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 2000; 69: 499-506.